These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 8404667)
21. Effects of FSH and testosterone on intratesticular insulin-like growth factor-I and specific germ cell populations in rats treated with gonadotrophin-releasing hormone antagonist. Spiteri-Grech J; Weinbauer GF; Bolze P; Chandolia RK; Bartlett JM; Nieschlag E J Endocrinol; 1993 Apr; 137(1):81-9. PubMed ID: 8388015 [TBL] [Abstract][Full Text] [Related]
22. Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide). Kangasniemi M; Wilson G; Parchuri N; Huhtaniemi I; Meistrich ML Endocrinology; 1995 Jul; 136(7):2881-8. PubMed ID: 7789313 [TBL] [Abstract][Full Text] [Related]
23. Regulation of Sertoli cell transferrin and sulfated glycoprotein-2 messenger ribonucleic acid levels during the restoration of spermatogenesis in the adult hypophysectomized rat. Roberts KP; Awoniyi CA; Santulli R; Zirkin BR Endocrinology; 1991 Dec; 129(6):3417-23. PubMed ID: 1954915 [TBL] [Abstract][Full Text] [Related]
24. Hormonal regulation of spermatogenesis in the hypophysectomized rat: cell viability after hormonal replacement in adults after intermediate periods of hypophysectomy. El Shennawy A; Gates RJ; Russell LD J Androl; 1998; 19(3):320-34; discussion 341-2. PubMed ID: 9639049 [TBL] [Abstract][Full Text] [Related]
25. Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents. Lue Y; Wang C; Lydon JP; Leung A; Li J; Swerdloff RS Andrology; 2013 Mar; 1(2):308-17. PubMed ID: 23408752 [TBL] [Abstract][Full Text] [Related]
26. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens. Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047 [TBL] [Abstract][Full Text] [Related]
27. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats. Shetty G; Wilson G; Huhtaniemi I; Shuttlesworth GA; Reissmann T; Meistrich ML Endocrinology; 2000 May; 141(5):1735-45. PubMed ID: 10803584 [TBL] [Abstract][Full Text] [Related]
28. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen. Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237 [TBL] [Abstract][Full Text] [Related]
29. Permanent effects of neonatal estrogen exposure in rats on reproductive hormone levels, Sertoli cell number, and the efficiency of spermatogenesis in adulthood. Atanassova N; McKinnell C; Walker M; Turner KJ; Fisher JS; Morley M; Millar MR; Groome NP; Sharpe RM Endocrinology; 1999 Nov; 140(11):5364-73. PubMed ID: 10537168 [TBL] [Abstract][Full Text] [Related]
31. GnRH agonists and antagonists stimulate recovery of fertility in irradiated LBNF1 rats. Meistrich ML; Wilson G; Shuttlesworth G; Huhtaniemi I; Reissmann T J Androl; 2001; 22(5):809-17. PubMed ID: 11545294 [TBL] [Abstract][Full Text] [Related]
32. Hypoprolactinemia does not prevent restoration of normal spermatogenesis in gonadotropin-suppressed, testosterone-replaced rats. Awoniji CA; Roberts D; Chandrashekar V; Hurst BS; Tucker KE; Schlaff WD J Androl; 1996; 17(1):35-40. PubMed ID: 8833739 [TBL] [Abstract][Full Text] [Related]
33. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone. Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659 [TBL] [Abstract][Full Text] [Related]
34. Temporal gene expression is restored concomitantly with germ cells in the experimentally regressed rat testis. Trasler JM; Alcivar AA; Awoniyi CA; Santulli R; Zirkin BR; Hecht NB Endocrinology; 1992 Jul; 131(1):297-304. PubMed ID: 1612009 [TBL] [Abstract][Full Text] [Related]
35. Suppression of spermatogenesis in a nonhuman primate (Macaca fascicularis) by concomitant gonadotropin-releasing hormone antagonist and testosterone treatment. Weinbauer GF; Surmann FJ; Nieschlag E Acta Endocrinol (Copenh); 1987 Jan; 114(1):138-46. PubMed ID: 3544633 [TBL] [Abstract][Full Text] [Related]
36. Androgen action on the restoration of spermatogenesis in adult rats: effects of human chorionic gonadotrophin, testosterone and flutamide administration on germ cell number. Meachem SJ; Wreford NG; Robertson DM; McLachlan RI Int J Androl; 1997 Apr; 20(2):70-9. PubMed ID: 9292316 [TBL] [Abstract][Full Text] [Related]
37. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration. Pogach LM; Lee Y; Gould S; Giglio W; Huang HF Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124 [TBL] [Abstract][Full Text] [Related]
38. Follicle-stimulating hormone amplifies the population of differentiated spermatogonia in the hypophysectomized testosterone-replaced adult rhesus monkey (Macaca mulatta). Marshall GR; Zorub DS; Plant TM Endocrinology; 1995 Aug; 136(8):3504-11. PubMed ID: 7628387 [TBL] [Abstract][Full Text] [Related]
39. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive. Bremner WJ; Bagatell CJ; Steiner RA J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925 [TBL] [Abstract][Full Text] [Related]
40. Quantitative cytological studies of spermatogenesis in intact and hypophysectomized rats: identification of androgen-dependent stages. Sun YT; Wreford NG; Robertson DM; de Kretser DM Endocrinology; 1990 Sep; 127(3):1215-23. PubMed ID: 2117524 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]